S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CASI CASI Pharmaceuticals Inc

3.225

-0.02 (-0.62%)

Last Updated: 04:16:35

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

CASI Pharmaceuticals (NASDAQ:CASI)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more CASI Pharmaceuticals Charts.

CASI Pharmaceuticals (NASDAQ:CASI)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more CASI Pharmaceuticals Charts.

Casi Pharmaceuticals, Inc. News

CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)
Wednesday 15 May 2024 (2 days ago) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 15 May 2024 (2 days ago) • Edgar (US Regulatory)

CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS AND FINANCIAL RESULTS
Tuesday 14 May 2024 (3 days ago) • PR Newswire (US)

Form EFFECT - Notice of Effectiveness
Monday 13 May 2024 (5 days ago) • Edgar (US Regulatory)

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS
Tuesday 9 April 2024 (1 month ago) • PR Newswire (US)

CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS
Thursday 28 March 2024 (2 months ago) • PR Newswire (US)

CASI Pharmaceuticals Report Positive Interim Phase 1 Data For BI-1206 In The Treatment Of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma In China
Tuesday 5 March 2024 (2 months ago) • PR Newswire (US)

CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINA
Friday 16 February 2024 (3 months ago) • PR Newswire (US)

CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 BUSINESS AND FINANCIAL UPDATES
Tuesday 14 November 2023 (6 months ago) • PR Newswire (US)

CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPA
Wednesday 8 November 2023 (6 months ago) • PR Newswire (US)

CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023 BUSINESS AND FINANCIAL UPDATES
Friday 11 August 2023 (9 months ago) • PR Newswire (US)

Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc. Enter Agreement to Transfer License of FOLOTYN® (Pralatrexate) in China to CASI Pharmaceuticals
Tuesday 1 August 2023 (10 months ago) • PR Newswire (US)

More Casi Pharmaceuticals, Inc. News Articles

Seychelle Environmental ... (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions